Introduction
============

Takayasu\'s arteritis (TA) is a type of primary systemic vasculitis that affects medium and large arteries, including the aorta and its main branches, as well as the pulmonary and coronary arteries^[@r01]^. The pathophysiology of TA is characterized by vessel wall inflammation, leading to thickening, stenosis, dilatation, and/or aneurysm formation of the affected vessels^[@r02]^. The signs and symptoms that reflect the context of the systemic inflammation or ischemia of an organ or limb include the presence of claudication, angiodynia, peripheral pulselessness, murmurs, severe systemic arterial hypertension, myocardium infarction, and ischemic stroke, among others^[@r02],[@r03]^.

In general, systemic autoimmune diseases affect more women than men, by a ratio of 2-10:1. Systemic lupus erythematosus and Sjogren\'s syndrome, for example, have ratios of 7-10:1, whereas rheumatoid arthritis and systemic sclerosis have ratios of 2-3:1^[@r04]^, while TA also tends to affect women more often, with a ratio of 1.2-29:1^[@r03],[@r05]^.

Although there have been various epidemiological studies regarding TA, none have reported the influence of gender on the clinical and laboratory manifestations and the vascular alterations at the onset of the TA. Although Sharma and Jain^[@r06]^ studied a possible role of sex in the distribution of the vascular lesions in TA and found a tendency for greater involvement of the abdominal aorta in men and the aortic arch and its branches in women, they did not specify whether their findings were cumulative or related to disease onset.

Thus, in the present study, we evaluated the initial clinical manifestations and the vascular alterations at the onset of TA according to gender.

Methods
=======

We evaluated 55 consecutive TA patients (17 men and 38 women) treated at the vasculitis unit of our tertiary facility between 1982 and 2012. We included only patients who were aged between 12 and 35 years at TA diagnosis and who met at least three of the six American College of Rheumatology classification criteria (1990)^[@r07]^. The study protocol was approved by our local ethics committee.

Demographic data, clinical manifestations, and vascular images were obtained through a systematic review of the patients\' medical records. The follow parameters were analyzed: (A) clinical manifestations: constitutional symptoms (weight loss, fever, fatigue), headache, dizziness, visual impairment (blindness), seizures, carotidynia, claudication, abdominal pain, chest pain, dyspnea, articular manifestations (arthritis/arthralgia), and erythema nodosum; (B) laboratory findings: C-reactive protein (CRP) (reference value: \< 5 mg/L) and erythrocyte sedimentation rate (ESR) (reference value: \< 19 mm/1^st^ hour); (C) comorbidities: myocardium infarction, ischemic stroke, systemic arterial hypertension, heart failure, type 2 diabetes mellitus, and dyslipidemia; (D) habit: smoking; and (E) echocardiography: aortic insufficiency.

All vascular images were obtained via angiography or computed tomography angiography, in which we evaluated the following parameters: stenosis/occlusion, aneurysm/vascular ectasia, and the anatomical location of these lesions.

The results were expressed as the means ± standard deviation (SD) or as percentages. We used the Student\'s *t*-test to analyze the parametric data and the Mann-Whitney U-test for the nonparametric data. The 95% confidence intervals (95% CI) of the percentages were calculated by binomial distribution. All calculations were performed using STATA ver. 7.0 statistical software (Stata Corp., College Station, TX, USA). A p-value \< 0.05 was considered statistically significant.

Results
=======

We analyzed records of 17 men and 38 women with TA, who were mostly Caucasian and had a comparable mean age between genders ([Table 1](#t01){ref-type="table"}). The clinical and laboratory characteristics and comorbidities of patients at disease onset are shown in [Table 1](#t01){ref-type="table"}. There was no gender difference regarding the distribution of signs and symptoms, except for abdominal pain (35.3% vs. 5.3%, p = 0.004, in men and women, respectively). The presence of aortic insufficiency, elevation of ESR and CRP, comorbidities, and habit (smoking) were also similar between genders.

###### 

Demographic, clinical, and laboratory characteristics of Takayasu\'s arteritis according to gender

  **Features**                         **Male (n = 17)**   **Female (n = 38)**   **P**
  ------------------------------------ ------------------- --------------------- -------
  Age at disease onset ± SD (years)    23.5 ± 7.6          25.3 ± 5.5            0.371
  Ethnicity: white (%)                 9 (52.9)            28 (73.7)             0.130
  **Clinical onset manifestations**                                              
  Weight loss (%)                      8 (47.1)            9(23.7)               0.083
  Fever(%)                             7(41.2)             10 (26.3)             0.270
  Fatigue (%)                          2 (11.8)            6 (15.8)              0.696
  Headache (%)                         1 (5.9)             6 (15.8)              0.308
  Dizziness (%)                        0                   2(5.3)                0.335
  Visual disturbances (%)              1 (5.9)             2(5.3)                0.926
  Amaurosis (%)                        1 (5.9)             0                     0.131
  Convulsions (%)                      1 (5.9)             0                     0.131
  Carotidynia (%)                      3 (17.6)            8(21.1)               0.770
  Upper limb claudication (%)          5 (29.4)            16 (42.1)             0.371
  Lower limb claudication (%)          2 (11.8)            12(31.6)              0.119
  Abdominal pain (%)                   6 (35.3)            2(5.3)                0.004
  Chest pain (%)                       0                   6 (15.8)              0.083
  Dyspnea (%)                          1 (5.9)             6 (15.8)              0.308
  Articular manifestations (%)         1 (5.9)             4 (10.5)              0.165
  Erythema (%)                         1 (5.9)             4 (10.5)              0.580
  Elevated ESR and/or CRP (%)          6 (35.3)            23 (60.5)             0.613
  Aortic insufficiency (%)             3 (17.6)            6 (15.8)              0.863
  **Comorbidities**                                                              
  Ischemic stroke (%)                  1 (5.9)             10 (26.3)             0.143
  Systemic arterial hypertension (%)   10 (58.8)           20 (52.6)             0.370
  Cardiac insufficiency (%)            0                   1 (2.6)               0.500
  Myocardium infarction (%)            0                   1 (2.6)               0.500
  Diabetes mellitus (%)                0                   2(5.3)                0.335
  Dyslipidemia (%)                     2 (11.8)            12(31.6)              0.119
  Smokers (%)                          2 (11.8)            4 (10.5)              0.892

CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; SD: standard deviation.

Regarding vascular lesions found in the first imaging for each patient, we observed that there was no gender difference in the frequency or the location of the stenoses/occlusions, which were more common in the carotid and subclavian arteries in women than men ([Table 2](#t02){ref-type="table"}). However, the presence of ascending aortic aneurysms was significantly more frequent in men (35.3 vs. 10.5%, p = 0.028), although other aneurysm locations did not differ between genders.

###### 

Angiographic characteristics of Takayasu\'s arteritis according to gender

  **Vessels**                 **Stenosis / Occlusion**   **Aneurysm /Ectasia**                                      
  --------------------------- -------------------------- ----------------------- ---------- ------------ ---------- -------
  **Male**                    **Female**                 **P**                   **Male**   **Female**   **P**      
  Left coronary (%)           0                          1 (2.6)                 1.000      0            0          1.000
  Right coronary (%)          0                          1 (2.6)                 1.000      0            0          1.000
  Left vertebral (%)          0                          6 (15.8)                0.131      1 (5.9)      0          0.131
  Right vertebral (%)         0                          6 (15.8)                0.131      1 (5.9)      0          0.131
  Left carotid (%)            7(41.2)                    20 (52.6)               0.487      0            0          1.000
  Right carotid (%)           6(35.3)                    20 (52.6)               0.200      0            0          1.000
  Left subclavian (%)         6(35.3)                    21 (55.3)               0.926      1 (5.9)      2(5.3)     0.926
  Right subclavian (%)        4(23.5)                    14 (36.8)               0.552      1 (5.9)      1 (2.6)    0.552
  Brachiocephalic trunk (%)   1 (5.9)                    5 (13.2)                0.391      2(11.8)      2(5.3)     0.391
  Pulmonary trunk (%)         0                          1 (2.6)                 0.500      0            1 (2.6)    0.500
  **Aortic**                                                                                                        
  Ascendant (%)               1 (5.9)                    2(5.3)                  0.926      6 (35.3)     4 (10.5)   0.028
  Cross (%)                   1 (5.9)                    4 (10.5)                0.168      2(11.8)      1 (2.6)    0.168
  Thoracic (%)                1 (5.9)                    7 (18.4)                0.108      4 (23.5)     3(7.9)     0.108
  Abdominal (%)               2 (11.8)                   7 (18.4)                0.552      1 (5.9)      1 (2.6)    0.552
  Infrarenal (%)              2 (11.8)                   8(21.1)                 0.131      1 (5.9)      0          0.131
  Left renal (%)              7(41.2)                    5 (13.2)                0.500      0            0          0.500
  Right renal (%)             6(35.3)                    5 (13.2)                0.131      1 (5.9)      1 (2.6)    0.131
  Upper mesenteric (%)        3 (17.6)                   7 (18.4)                0.945      0            0          1.000
  Lower mesenteric (%)        2 (11.8)                   3(7.9)                  0.645      0            0          1.000
  Celiac trunk (%)            2 (11.8)                   4 (10.5)                0.131      1 (5.9)      0          0.131
  Left iliac (%)              1 (5.9)                    6 (15.8)                0.308      0            0          1.000
  Right iliac (%)             1 (5.9)                    5 (13.2)                0.424      0            0          0.500

Multivariate analysis showed that male gender was a risk factor for the occurrence of abdominal pain (OR, 18.75; 95% CI, 2.89-121.54) and aortic aneurysm (OR, 9.51; 95% CI, 1.94-46.70) ([Table 3](#t03){ref-type="table"}).

###### 

Multivariate analysis for gender

  **Variate**                 **OR**   **95% CI**
  --------------------------- -------- -------------
  Age at disease onset        0.96     0.86-1.07
  Abdominal pain              18.75    2.89-121.54
  Ascendant aortic aneurysm   9.51     1.94-46.70

Discussion
==========

To our knowledge, the present study is the first to analyze the presentation of TA in terms of clinical manifestations and vascular imaging alterations according to gender. Compared to women, men had a higher prevalence of abdominal pain and ascending aortic aneurysm at diagnosis of TA.

Despite the existence of various epidemiological series regarding TA patients ^[@r03],[@r08]-[@r19]^, none have compared disease presentation between men and women. In this study, all of the parameters refer clearly to the onset of symptoms before any drug or surgical treatment is initiated. Furthermore, we evaluated only patients aged between 12 and 35 years to exclude clinical manifestations, comorbidities, or vascular changes that could be related to advanced age rather than to TA alone.

Gender is likely a determinant in the prognosis of several rheumatic diseases. For example, systemic lupus erythematosus tends to have a worse prognosis in men, although this view remains controversial^[@r20]-[@r23]^. In rheumatoid arthritis, female gender has been associated with higher scores of disease activity^[@r24]^ and is an established predictor of radiographic progression^[@r25]^. Furthermore, the inflammatory response appears to be more severe in women than in men as well as the presence of giant cell arteritis and polymyalgia rheumatica^[@r26]^. However, there are no studies that have evaluated sex as a determining factor in TA prognosis. Our results showed a strong association between the presence of aortic aneurysm and male gender, thereby correlating this gender to a poor prognostic factor.

Other factors classically associated with poor prognosis in TA include the following: retinopathy, hypertension, severe aortic regurgitation, and the presence of aortic or arterial aneurysm, as mentioned previously^[@r27]^. Subsequently, the presence of severe functional disability and cardiac involvement were reported as predictors of either death or major events on follow-up^[@r28]^. Sharma and Jain^[@r06]^ reported a trend toward a higher frequency of hypertension in men with TA compared with women, but this was not observed in the present study. Chugh et al^[@r29]^ studied renovascular hypertension in Indians with AT and also found no difference between genders. Aortic regurgitation was also similar in both sexes in our series, in contrast to the findings of Kobayashi and Numano^[@r30]^, who reported a higher prevalence of aortic regurgitation in women.

Our study was limited by its retrospective nature and complicated by typical problems of this type of cohort. Furthermore, the collected data were dependent on the medical records and even though all of the variables were true at the time of diagnosis, we do not know if they accurately reflected manifestations at disease onset.

Conclusion
==========

Abdominal pain and ascending aortic aneurysms occurred more frequently in men with TA and the male gender was an independent risk factor for such findings. Nonetheless, further studies will be needed to confirm male gender as a predictor of poor prognosis in TA.
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